Patent · US Active

DNA polymerase IIIC inhibitors and use thereof

US10836772B2 · kind B2 · utility

0Cited by
5References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 2020
Grant dateNov 17, 2020
Priority date
Expiry dateJun 15, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/519
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds and methods useful for inhibiting the DNA polymerase IIIC enzyme. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of Gram-positive bacterial infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.